| Rubin, Samuel (JSR Corp 201903– Director Business Development + Licensing for Selexis in San Francisco) |
Business Development Manager / Strategy Manager |
JSR Corporation (Group) |
United States (USA) |
| Rubow, Reinhard (Retina Implant 201603 CFO) |
Chief Financial Officer (CFO) |
Retina Implant AG |
Germany |
| Ruch, Matthias (Evonik 202012 Head of External Communications) |
Public Relations Manager / Investor Relations Manager |
Evonik (Group) |
Germany |
| Ruchko, Sergey (IBC Generium LLC 201306 CEO) |
Chief Executive Officer (CEO) |
IBC Generium LLC |
Russian Federation |
| Ruckel, Linda (Boehringer 202002 Associate Director Media + Corporate Reputation) |
Public Relations Manager / Investor Relations Manager |
Boehringer Ingelheim (Group) |
United States (USA) |
| Ruckes, Tobias (Qiagen 201304– Head Emerging Business + Marketing Molecular Diagnostics before artus) |
Sales Manager / Marketing Manager |
Qiagen (Group) |
Germany |
| Rudat, Annika (EBD Group 201010 EBD München) |
n. a. |
Informa plc (Group) |
Germany |
| Rudischhauser, Doris (Dynamics Group 202208 Consultant Crisis Communication) |
Public Relations Manager / Investor Relations Manager |
Dynamics Group AG |
Switzerland |
| Rudolph, Ansgar (Gesundheitswirtschaft NordWest 201010–201312 Head Office LEFT 12/13 before BioRegioN + Biometi e. V.) |
Business Development Manager / Strategy Manager |
Gesundheitswirtschaft Nordwest e. V. |
Germany |
| Rudolph, Carsten (Ethris 201301 Managing Director + Co-Founder) |
Managing Director |
Ethris GmbH |
Germany |
| Rudolph, Karl Lenhard (University of Ulm 200808) |
n. a. |
University of Ulm |
Germany |
| Rueega, Priska (GlycArt CFO) |
Chief Financial Officer (CFO) |
Roche (Group) |
Switzerland |
| Rufenacht, Daniel (SGS 202012 Group VP Corporate Communciations + Sustainability) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
| Ruffieux, Pierre-Alain (Lonza 202011– CEO before Roche + Novartis + Serono) |
Chief Executive Officer (CEO) |
Lonza (Group) |
Switzerland |
| Rufo, Caroline (MacDougall 202003) |
Public Relations Manager / Investor Relations Manager |
MacDougall Advisors Inc. |
United States (USA) |
| Ruge, Stefan (Bruker 200908 Managing Director Bruker Daltonik GmbH) |
Managing Director |
Bruker (Group) |
Germany |
| Ruhe, Jens (Scimab GmbH 201611– Managing Director) |
Managing Director |
SciRhom GmbH |
Germany |
| Ruile, Peter (MorphoSys 201106– Director Business Development before Ascenion GmbH COO) |
Business Development Manager / Strategy Manager |
MorphoSys (Group) |
Germany |
| Rujan, Tamas (Epigenomics 200605) |
n. a. |
Epigenomics (Group) |
Germany |
| Rule, Chelsea (MacDougall Advisors 202305) |
n. a. |
|
|
| Rullkötter, Jürgen (Univ Oldenburg 201009 Professor and DirectorICBM) |
Professor |
University of Oldenburg (Carl von Ossietzky University) |
Germany |
| Rummelt, Andreas (InterPharmaLink 202011 CEO + Partner before Novartis + Sandoz) |
Chief Executive Officer (CEO) |
InterPharmaLink AG |
Switzerland |
| Runge, Dieter (Primacyt Cell Culture Technology 201104 Managing Director) |
Managing Director |
Primacyt Cell Culture Technology GmbH |
Germany |
| Ruoff, Michael (Think.Health Ventures 201812 Partner) |
Partner (venture partner) |
Think.Health GmbH (Think.Health Ventures) |
Germany |
| Rupalla, Katrin (Ymmunobio 202206 CEO) |
Chief Executive Officer (CEO) |
Ymmunobio AG |
Switzerland |
| Russell, Clare (formerly Jones) (BioStrata 201404– Managing Director before Chempetitive UK + Alto Marketing) |
Public Relations Manager / Investor Relations Manager |
BioStrata Ltd. (Biostrata Marketing) |
United Kingdom (GB) |
| Russell, Simon (Creabilis 201205– CBO before Novartis Pharma AG + AstraZeneca + ICI Pharmaceuticals) |
Chief Business Officer (CBO) |
Creabilis (Group) |
Luxembourg |
| Russo, René (Arsanis 201702 CEO) |
Chief Executive Officer (CEO) |
Arsanis (Group) |
United States (USA) |
| Russo, Tony (Russo Partners 201701) |
Public Relations Manager / Investor Relations Manager |
Russo Partners LLC |
United States (USA) |
| Rutten, Boyd (Gilde Investment 201903c– Senior Associate before EQT Partners) |
Investment Manager |
Gilde Investment (Group) |
Netherlands |
| Ruzicka, Viktor (BioVendor 201307 CEO) |
Chief Executive Officer (CEO) |
BioVendor (Group) |
Czech Republic |
| Rußwurm, Stefan (SIRS-Lab 200503) |
n. a. |
Endress+Hauser (Group) |
Germany |
| Ryals, John (Metabolon 201806– Board Director before CEO + Co-Founder) |
Board member, non-executive |
Metabolon (Group) |
United States (USA) |
| Ryan, Connie (Streck 201802 CEO) |
Chief Executive Officer (CEO) |
Streck Inc. |
United States (USA) |
| Ryan, J. Michael (Asceneuron 201704 CMO) |
Chief Medical Officer (CMO) |
Asceneuron S.A. |
Switzerland |
| Ryan, James (BioNTech 202309– Chief Legal Officer + Board Member before General Counsel + SVP Legal + IP joined 7/18) |
General Counsel / Chief Legal Officer (CLO) |
BioNTech (Group) |
Germany |
| Ryazantsev, Yan (Russia (govt) 201203 Director Investment + Expertise Dept at Russian Venture Company) |
Investment Manager |
Russia (govt) |
Russian Federation |
| Rübenach, Susanne (Germany (govt) 201307 Investment Manager at ERP-Startfonds at KfW) |
Investment Manager |
Germany (govt) |
Germany |
| Rübsamen-Schaeff, Helga (AiCuris 200603– before Bayer HealthCare anti-infectives research) |
Chief Executive Officer (CEO) |
STRÜNGMANN Group (family Strüngmann) |
Germany |
| Rückle, Frank (Methrom 201301– Managing Director of Deutsche Methrom GmbH & Co KG joined 28 years before) |
Managing Director |
Metrohm (Group) |
Germany |
| Rüdiger, Manfred (Ariceum Therapeutics 202206 CEO before Catalym + Affectis + Kiadis Pharma + LSP Munich) |
Chief Executive Officer (CEO) |
Ariceum Therapeutics (Group) |
Germany |
| Rüegg, André (Bellevue Group 201409 CEO of Bellevue Asset Management) |
Chief Executive Officer (CEO) |
Bellevue (Group) |
Switzerland |
| Rüger, Simon (ZIM Plant Technology GmbH 201204 Managing Director) |
Managing Director |
ZIM Plant Technology GmbH |
Germany |
| Rüger, Sven (Sovicell GmbH 201208 CFO) |
Chief Financial Officer (CFO) |
Sovicell GmbH |
Germany |
| Rüggeberg, Hermann (Impetus GmbH 200902 Managing Director) |
Managing Director |
Impetus Bioscience (Group) |
Germany |
| Rüggeberger, Hermann |
n. a. |
Impetus Bioscience (Group) |
Germany |
| Rüsch, Jacqueline Ruedin (Privilège Ventures 202209 Founding General Partner) |
General Partner (venture partner) |
Privilège Ventures (CH) |
Switzerland |
| Rüschmeier, Henner |
n. a. |
M.M. Warburg (Group) |
Germany |
| Rüsenberg, Marcus |
n. a. |
Geneworx AG |
Germany |
| Rüssmeier, Nick (Optimare 201204 Mechanical Engineering) |
Engineer |
Aerodata (Group) |
Germany |
| Rüterjans, Heinz |
n. a. |
University of Frankfurt (Goethe-Universität) |
Germany |
| Rüttinger, Dominik (Bayer 202110– Head of Research + Early Development for Oncology before Roche pRED + Micromet) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Räbiger, Thomas (BMG Labtech 201110 Managing Director) |
Managing Director |
BMG Labtech (Group) |
Germany |
| Rädler, Ulf (ibidi 200311) |
n. a. |
ibidi GmbH |
Germany |
| Röder, Albert (StemVac GmbH 201602– Managing Director) |
Managing Director |
|
|
| Röhm, Robin (JRM Genomics 201806– Director) |
Board member, executive |
JRM Genomics Ltd. (Janus Genomics) |
United Kingdom (GB) |
| Röhr, Anneli |
n. a. |
University of Kiel (Christian-Albrechts-Universität, CAU) |
Germany |
| Röll, Marcel (Wave Biotech AG 200605 CEO) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Switzerland |
| Römer, Axel (A&M Labor 201201 Managing Director) |
Managing Director |
A&M Labor für Analytik und Metabolismusforschung Service Gmb |
|
| Römer, Michael (Merck KGaA 200511) |
n. a. |
Merck (DE) (Group) |
Germany |
| Rönicke, Susanne (RS Zelltechnik GmbH 201506 Managing Director) |
Managing Director |
RS Zelltechnik GmbH |
Germany |
| Röpke, Werner (Techlab GmbH 201204 Managing Director) |
Managing Director |
Techlab GmbH |
Germany |
| Rösch, Paul (Univ Bayreuth 201504 Professor at Research Center for Bio-Macromolecules) |
Professor |
University of Bayreuth |
Germany |
| Röskamp, Jakob (Traceless Materials 202212 CFO) |
Chief Financial Officer (CFO) |
Traceless Materials GmbH |
Germany |
| Rösler, Philipp (Germany (govt) Minister Economics + Technology before Health + Niedersachsen (govt) Minister Economics) |
Minister |
Germany (govt) |
Germany |
| Rötger, Antje (Carpegen GmbH 201108 Managing Director) |
Managing Director |
Carpegen GmbH |
Germany |
| Röver, Stephan (Roche 201006 Scientific Expert for Discovery Chemistry) |
Researcher (industry) |
Roche (Group) |
Switzerland |
| Saalfeld, Sonja (Techlab GmbH 201204 Managing Director) |
Managing Director |
Techlab GmbH |
Germany |
| Saarela, Sakari (UB FIGG 202309 Partner) |
Partner (venture partner) |
United Bankers (UB) (Group) |
|
| Saavedra, Hugo (Kyan Therapeutics 202304 CEO) |
Chief Executive Officer (CEO) |
Kyan Technologies Pte Ltd. |
Singapore |
| Sabry, James H. (Roche 201808– Global Head Partnering joined Genentech 2010 before Arete Therapeutics + Cytokinetics) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Switzerland |
| Sabzevari, Helen (Intrexon 202001– CEO joined 2017 formerly Merck Serono) |
Chief Executive Officer (CEO) |
Precigen (Group) |
United States (USA) |
| Sachdev, Rakesh (Sigma-Aldrich 201506 CEO before 200811– CFO) |
Chief Financial Officer (CFO) |
Merck (DE) (Group) |
United States (USA) |
| Sachse, Christoph (Univ Tübingen 201504– Site Head Berlin NMI TT Pharmaservices before siTools + Cenix BioScience) |
n. a. |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Sachsenmaier, Christoph (Epimune GmbH 201805 BusDev before Ribolution Health + Epigenomics + ApoCell + Beckman Coulter) |
Business Development Manager / Strategy Manager |
Epimune GmbH |
Germany |
| Sack, Stephan (Harlan Laboratories 200910 Manager Analytical Services at Harlan Laboratories Ltd) |
Laboratory Manager (industry) |
Envigo (Group) |
Switzerland |
| Sackers, Roland (Qiagen 200408 CFO) |
Chief Financial Officer (CFO) |
Qiagen (Group) |
Netherlands |
| Sadeh, Mohammad Javad (JRM Genomics 201806– Director) |
Board member, executive |
JRM Genomics Ltd. (Janus Genomics) |
United Kingdom (GB) |
| Sadtler, Stefan (Sarstedt 201705 Director of Marketing Life Science) |
Sales Manager / Marketing Manager |
Sarstedt (Group) |
Germany |
| Sagan, Paul (LaVoieHealthScience 201909) |
Public Relations Manager / Investor Relations Manager |
LaVoieHealthScience (LHS) |
United States (USA) |
| Sagar, Bijoy (Bayer 202301 Chief Information + Digital Transformation Officer) |
Chief Information Officer (CIO) / Chief Digital Officer |
Bayer (Group) |
Germany |
| Sager, Cédric (Debiopharm 201403 CEO of Debiopharm Research & Manufacturing SA) |
Chief Executive Officer (CEO) |
Debiopharm (Group) |
Switzerland |
| Sagmeister, Bernhard (Austria (govt) 201107 Managing Director of aws) |
Managing Director |
Austria (govt) |
Austria |
| Sahasrabudhe, Priyanka (Navigo Proteins 202309 Senior Business Development Manager) |
Business Development Manager / Strategy Manager |
UV-Cap (Vetter family office) (Group) |
Germany |
| Sahin, Gencer (Hamburg (govt) 201603 Investment Manager at Innovationsstarter Fonds Hamburg) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Sahin, Ugur (BioNTech 201207 Managing Director BioNTech + Ribological GmbH) |
Managing Director |
BioNTech (Group) |
Germany |
| Said, Maya (Transgene 201706– Non-Executive Board Member before Novartis + Sanofi + Boston Consulting) |
Board member, non-executive |
Mérieux (Group) |
France |
| Saikia, Rohan (Great Point Partners 202101 Managing Director) |
Managing Director |
Great Point Partners LLC |
United States (USA) |
| Saiyed, Taslimarif (Tata Institute of Fundamental Research 201102 Director Strategic Alliances + BusDev at C-CAMP) |
Business Development Manager / Strategy Manager |
Tata Institute of Fundamental Research |
India |
| Salahdine, Younes (NeraCare 202005 Director of Corporate Development) |
Business Development Manager / Strategy Manager |
NeraCare GmbH |
Germany |
| Salanti, Ali (VAR2 Pharmaceuticals 202007 CEO + Founder + Prof at Univ Copenhagen) |
Chief Executive Officer (CEO) |
VAR2 Pharmaceuticals (Group) |
Denmark |
| Salhov, Aviv (Pronto Diagnostics 201010 VP Marketing + Operations) |
Sales Manager / Marketing Manager |
Pronto Diagnostics Ltd. |
Israel |
| Sallam, Ahmed (Cysal GmbH 201210– Managing Director + Co-founder) |
Managing Director |
Cysal GmbH |
Germany |
| Salzmann, Michael (Neurimmune 2008– COO + General Manager before Bruker + Roche + ETH Zürich) |
Chief Operating Officer (COO) |
Neurimmune AG |
Switzerland |
| Samama, Laurent (Jolt Capital 202211 Managing Partner) |
Managing Partner |
Jolt Capital S.A.S. |
France |
| Sameith, Janin (Hessen (govt) 202001 Senior Project Manager Life Sciences + Biobased Economy at Technologieland Hessen |
Cluster Manager |
Hessen (Hesse) (govt region) |
Germany |
| Sampath, Rangarajan (Siemens 202112 Head of Center for Innovation in Diagnostics at Siemens Healthineers) |
President/Director/Head of Research Organisation/Unit |
Siemens (Group) |
Germany |
| Sampers, Thomas (Renolit 202005 Head of Renolit Healthcare) |
President/Director/Head Business Group/Unit/Division |
Renolit (Group) |
Germany |
| Samuelsson, Per (Odlander Fredrikson 202102 at HealthCap VI LP) |
Investment Manager |
Odlander Fredrikson (Group) |
Sweden |
| Sanchez, Jean-Charles (Univ Geneva 201204 Professor + Director Biomedical Proteomics Research Group) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 64 65 66 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
